The American Diabetes Association offered advice on prevention, screening, and treatment of diabetic peripheral neuropathies and cardiovascular autonomic neuropathies.
Mean HbA1c was 5.7% in the African-American participants with sickle cell trait and 6.0% in those without, despite similar mean fasting and two-hour glucose values.
Continuous glucose monitoring associated with lower HbA1c in type 1 diabetes treated with insulin injection
An editorial accompanying the two trials of continuous glucose monitoring stressed that the physicians involved had extensive experience with the technology and noted that the necessary changes in lifestyle and insulin dosing can be variable and complicated.
This month's quiz asks readers to evaluate a 43-year-old man with multiple chronic complications from his diabetes, including end-stage kidney disease requiring hemodialysis, gastroparesis, frequent hypoglycemia with hypoglycemic unawareness, painful peripheral neuropathy, and proliferative retinopathy.
Review: In type 2 diabetes, sodium##ndash;glucose cotransporter 2 inhibitors do not increase major CV events or mortality
The meta-analysis included 37 trials that compared canagliflozin, dapagliflozin, or empagliflozin to placebo or other active antidiabetic treatments.
Semaglutide reduced a composite of CV events at two years in patients with type 2 diabetes and high CV risk
Semaglutide, a new once-weekly glucagon-like peptide-1 (GLP-1) analogue, reduced cardiovascular (CV) events compared to placebo, according to a manufacturer-sponsored study.
The consensus statement advises physicians about ways to manage people with type 1 diabetes who exercise regularly, including glucose targets for safe and effective exercise and nutritional and insulin dose adjustments to protect against exercise-related glucose excursions.